Ankit Mangla; Udit Yadav.
Last Update: May 14, 2022.
Continuing Education Activity
This activity reviews the evaluation, diagnosis, treatment, and latest advances in the field of leiomyosarcoma. It will discuss the existing literature and present the most recent evidence regarding treatment options available for patients diagnosed with soft-tissue sarcoma/leiomyosarcoma. It will also review the ongoing phase I-II trials and medications currently under evaluation to treat soft-tissue sarcoma/leiomyosarcoma. This activity will also highlight the interprofessional team’s role in managing leiomyosarcoma to optimize patient outcomes.
- Identify the etiology of leiomyosarcoma.
- Outline the management options available for leiomyosarcoma.
- Summarize the latest molecules and clinical trials exploring treatment options for all soft-tissue sarcoma, including leiomyosarcoma.
- Explain interprofessional team strategies for improving care coordination and communication to advance leiomyosarcoma and improve outcomes.